Literature DB >> 29940237

Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.

Danilo Arnone1, Smita Saraykar2, Haitham Salem2, Antonio L Teixeira2, Robert Dantzer3, Sudhakar Selvaraj4.   

Abstract

Activation of the kynurenine pathway is one of the described mechanisms by which inflammation can induce depression. It involves multiple pathways including interference with the bioavailability of tryptophan central to the synthesis of the neurotransmitter serotonin. In this systematic review, we examine the relationship between kynurenine metabolites (kynurenine, kynurenic acid, tryptophan, quinolinic acid, the ratio of kynurenine and tryptophan) and mood disorders by conducting a meta-analysis. Fifty-six studies were identified, 21 met inclusion criteria and 14 were deemed suitable (9 investigating unipolar depression and 5 bipolar disorder). We found decreased levels of kynurenine in unipolar major depression vs. healthy controls but studies were significantly heterogeneous in nature. No significant differences were found in tryptophan levels or kynurenine/tryptophan ratios. Kynurenine metabolites are likely to play a role in major depression but an exact etiological role in mood disorder seem complex and requires further research.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Depression; Inflammation; Kynurenine; Mood disorder; Quinolinic acid; Tryptophan

Mesh:

Substances:

Year:  2018        PMID: 29940237      PMCID: PMC6686193          DOI: 10.1016/j.neubiorev.2018.05.031

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  65 in total

1.  Major depression is a risk factor for seizures in older adults.

Authors:  D C Hesdorffer; W A Hauser; J F Annegers; G Cascino
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

2.  Immune-mediated inflammation as a driver of obesity and comorbid conditions.

Authors:  Barbara Strasser
Journal:  Obesity (Silver Spring)       Date:  2017-06       Impact factor: 5.002

3.  Depressed states and indolealkylamines.

Authors:  A J Coppen
Journal:  Adv Pharmacol       Date:  1968

4.  Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report.

Authors:  Eva Z Reininghaus; Roger S McIntyre; Bernd Reininghaus; Simon Geisler; Susanne A Bengesser; Nina Lackner; Karen Hecht; Armin Birner; Fabian Kattnig; Renate Unterweger; Hans-Peter Kapfhammer; Sieglinde Zelzer; Dietmar Fuchs; Harald Mangge
Journal:  Bipolar Disord       Date:  2013-12-12       Impact factor: 6.744

5.  Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus.

Authors:  Stefania Bonaccorso; Valentina Marino; Massimo Biondi; Franca Grimaldi; Flora Ippoliti; Michael Maes
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

Review 6.  The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.

Authors:  Michele Fornaro; Marco Solmi; Nicola Veronese; Domenico De Berardis; Elisabetta Filomena Buonaguro; Carmine Tomasetti; Giampaolo Perna; Antonio Preti; Mauro Giovanni Carta
Journal:  Int Rev Psychiatry       Date:  2017-07-06

Review 7.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

Review 8.  COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.

Authors:  Norbert Müller
Journal:  Curr Opin Investig Drugs       Date:  2010-01

9.  Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.

Authors:  Jonathan Savitz; Wayne C Drevets; Chelsey M Smith; Teresa A Victor; Brent E Wurfel; Patrick S F Bellgowan; Jerzy Bodurka; T Kent Teague; Robert Dantzer
Journal:  Neuropsychopharmacology       Date:  2014-07-30       Impact factor: 7.853

10.  Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.

Authors:  Armin Birner; Martina Platzer; Susanne Astrid Bengesser; Nina Dalkner; Frederike T Fellendorf; Robert Queissner; Rene Pilz; Philipp Rauch; Alexander Maget; Carlo Hamm; Simone Herzog-Eberhard; Harald Mangge; Dietmar Fuchs; Natalie Moll; Sieglinde Zelzer; Gregor Schütze; Markus Schwarz; Bernd Reininghaus; Hans-Peter Kapfhammer; Eva Z Reininghaus
Journal:  PLoS One       Date:  2017-02-27       Impact factor: 3.240

View more
  25 in total

Review 1.  Antidepressants in inflammatory bowel disease.

Authors:  Antonina Mikocka-Walus; Alexander C Ford; Douglas A Drossman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-18       Impact factor: 46.802

Review 2.  Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder.

Authors:  Kenny L Chan; Flurin Cathomas; Scott J Russo
Journal:  Physiology (Bethesda)       Date:  2019-03-01

3.  Peripheral and central kynurenine pathway abnormalities in major depression.

Authors:  Elisabeth R Paul; Lilly Schwieler; Sophie Erhardt; Sandra Boda; Ada Trepci; Robin Kämpe; Anna Asratian; Lovisa Holm; Adam Yngve; Robert Dantzer; Markus Heilig; J Paul Hamilton; Martin Samuelsson
Journal:  Brain Behav Immun       Date:  2022-01-06       Impact factor: 19.227

4.  Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.

Authors:  Alex D Klausing; Tsutomu Fukuwatari; David J Bucci; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-25       Impact factor: 4.530

Review 5.  Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?

Authors:  C D Moulton; P Pavlidis; C Norton; S Norton; C Pariante; B Hayee; N Powell
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

6.  The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites.

Authors:  Francesco Bartoli; Błażej Misiak; Tommaso Callovini; Daniele Cavaleri; Riccardo M Cioni; Cristina Crocamo; Jonathan B Savitz; Giuseppe Carrà
Journal:  Mol Psychiatry       Date:  2020-10-19       Impact factor: 15.992

7.  The role of kynurenine pathway and kynurenic aminotransferase alleles in postpartum depression following cesarean section in Chinese women.

Authors:  Chengxuan Quan; Saiying Wang; Kaiming Duan; Jiahui Ma; Heya Yu; Mi Yang; Na Hu; Ge Long; Guang Zeng; Zhendong Huang
Journal:  Brain Behav       Date:  2020-02-26       Impact factor: 2.708

8.  Altered kynurenine pathway metabolites in a mouse model of human attention-deficit hyperactivity/autism spectrum disorders: A potential new biological diagnostic marker.

Authors:  Yuki Murakami; Yukio Imamura; Kuniaki Saito; Daisuke Sakai; Jun Motoyama
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

9.  Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.

Authors:  Kaat Hebbrecht; Katrien Skorobogatov; Erik J Giltay; Violette Coppens; Livia De Picker; Manuel Morrens
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Psychological symptoms and salivary inflammatory biomarkers in patients with dentofacial deformities: a case-control study.

Authors:  Maria C C Volkweis; Gabriela W Neculqueo; Raquel D S Freitas; Ana P A Dagnino; Guilherme G Fritscher; Tatiana Q Irigaray; Maria M Campos
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.